DAVNUO

Class [005]
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone diseases and for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, cancer, cardiovascular diseases, the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy and Parkinson's diseases, and for brain, movement, ocular motility and spinal cord diseases, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, namely, growth and thyroid disorders, diabetes, and obesity, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental health disorders, metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome, migraines, neurodegenerative diseases and disorders, neurological diseases, namely, brain injury, spinal cord injury, seizure disorders, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases